Status:
COMPLETED
Study of Fat Malabsorption by Lipiblock Versus Xenical
Lead Sponsor:
University of Campinas, Brazil
Collaborating Sponsors:
Germed Pharma
Conditions:
Obesity
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Obesity is a chronic condition with fat-rich diets playing a major role in its etiology. Pharmacological therapy has been proposed for weight loss and maintenance. This study aims to study the intesti...
Detailed Description
The overweight and obesity epidemic affects approximately 1.6 millions of people worldwide. Obesity is a chronic condition, associated with premature death, co-morbidities, risk factors for main cardi...
Eligibility Criteria
Inclusion
- Obesity
- BMC (Body Mass Index) between 30 to 40 kg/m2
- Women
- 18 to 45 years
- Premenopausal stage
Exclusion
- Relevant diseases (diabetes, cardiovascular, gastrointestinal, renal and hepatic diseases, endocrine disorders, hemoglobinopatHy or neoplasm in the last three years)
- Chemical or natural laxatives
- Weight variation greater than 5% in the preceding 3 months
- Surgery for weight reduction
- Drugs to obesity control and/or oral corticosteroids anti-inflammatory in the last three months
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01170806
Start Date
October 1 2009
End Date
April 1 2010
Last Update
January 31 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/University of Campinas (UNICAMP)
Campinas, São Paulo, Brazil, 13083-878